Developing Drugs to Cross the Blood-Brain Barrier for Alzheimer's Disease
Author Information
Author(s): Williams A. Banks
Primary Institution: Saint Louis University School of Medicine
Hypothesis
Can drugs be effectively delivered across the blood-brain barrier to treat Alzheimer's disease?
Conclusion
New classes of drugs that can cross the blood-brain barrier show promise for treating Alzheimer's disease.
Supporting Evidence
- Drugs that can cross the blood-brain barrier are crucial for treating Alzheimer's disease.
- Peptides and antibodies have been explored as potential treatments but face challenges in crossing the barrier.
- Small amounts of drugs can have significant effects in the brain, highlighting the importance of effective delivery.
Takeaway
Scientists are trying to find ways to get medicine into the brain to help people with Alzheimer's disease, which is really hard because of a barrier that protects the brain.
Methodology
The article reviews mechanisms of drug delivery across the blood-brain barrier and discusses specific examples relevant to Alzheimer's disease.
Potential Biases
Potential conflicts of interest due to the author's consulting roles and funding sources.
Limitations
The complexity of the blood-brain barrier and the variability in how different substances interact with it can complicate drug delivery.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website